ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Sanjit Kumar Agrawal

Tata Medical Center, Kolkata, India

Dr Sanjit Agrawal speaks to ecancer about the oncologic safety of breast conservation following NACT in women with locally advanced breast cancer.

He says that this study is a retrospective observational study of 411 non-metastatic locally advanced breast cancer (LABC) patients who received neoadjuvant chemotherapy (NACT) followed by surgery from 2011 to 2016.

The study found that BCS is technically feasible in LABC patients.

Dr Agrawal concludes that LABC patients who respond well to NACT can be offered BCS without compromising survival outcomes.

Read the full study here